The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey

Medicine, Internal medicine, Bevacizumab, Hepatocellular carcinoma, Concomitant, Gastroenterology, Atezolizumab, Proportional hazards model, Adverse effect, Surgery, Cancer, Chemotherapy, Nivolumab